We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sound Waves Diagnose Blood-Related Diseases

By LabMedica International staff writers
Posted on 16 Jul 2013
A method has been developed that can rapidly quantify variations in the morphology of single red blood cells (RBCs) using light and sound. More...


When irradiated with a laser pulse, an RBC absorbs the optical energy and emits an ultrasonic pressure wave called a photoacoustic wave, which contains distinctive features that can be used to identify the erythrocyte’s size.

Biophysicists at Ryerson University (Toronto, ON, Canada) used a special photoacoustic microscope that detects sound. They were able to differentiate healthy red blood cells from irregularly shaped red blood cells with high confidence, using a very small sample size. Because each measurement takes only fractions of a second, the method could eventually be incorporated into an automated device for rapid characterization of red blood cells from a single drop of blood obtained in the clinic.

All measurements were completed using a photoacoustic microscope developed by Kibero (Saarbrücken, Germany). This is an Olympus IX81 inverted optical microscope (Tokyo, Japan) fitted with a transducer above the sample stage. Deviations from the regular biconcave shape of a red blood cell are a significant indicator of blood-related diseases, whether they result from genetic abnormalities, from infectious agents, or simply from a chemical imbalance.

As an example, malaria patients' red blood cells are irregularly swollen, while those of patients with sickle cell anemia or drepanocytosis take on a rigid, sickle shape. The scientists used a single wide-bandwidth transducer sensitive to frequencies between 100 MHz and 500 MHz, to differentiate healthy RBCs from irregularly shaped RBCs, such as echinocytes, spherocytes, and swollen RBCs, with high confidence using sample size of just 21 erythrocytes.

The authors concluded that the photoacoustic spectral methods are a first step toward an automated process for the detection of RBC abnormalities via morphological identification with good sensitivity. With some refinement, these methods could eventually be used in a clinical setting to help diagnose RBC pathology using just a single drop of blood. Michael Kolios, PhD, the senior author of the study said, “We plan to make specialized devices that will allow the detection of individual red blood cells and analyze the photoacoustic signals they produce to rapidly diagnose red blood cell pathologies.” The study was published on July 2, 2013, in the Biophysical Journal.

Related Links:

Ryerson University
Kibero
Olympus



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.